Towards live imaging in proton therapy
ASG Superconductors with HZDR combine magnetic resonance imaging with particle beams.
ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world’s first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy, combining a rotating open MRI device for the LINAC-MR system Alberta Health Services, with an actively scanned clinical-akin proton beam at OncoRay, the Dresden-based National Center for Radiation Research in Oncology. The rotating MRI device is produced by ASG Superconductors, using the MROpen Evo technology-based helium-free superconducting MgB2 magnet. Real-time MRI would make it possible to synchronize the proton beam to tumor motion during radiation dose delivery. So far, this has been impossible and therefore was a limiting factor for treating moving tumors with this promising cancer therapy.
NEWS
More accurate tumour treatment thanks to superconductive ASG Superconductors technology
The world's first scientific prototype combining real time magnetic [...]
The Italian Health Minister Orazio Schillaci visiting MRopenEVO booth at RSNA 2023
Get ready for an exceptional week of learning and [...]
Marco Nassi appointed CEO of ASG Superconductors
ASG Superconductors SpA announces that the Board of Directors [...]
Smart Walking meets MROpen EVO
That's why we work everyday: the best mri experience [...]
MROpenEVO @ ARAB HEALTH 23
Spreading the best mri experience advantages enabled by MROpenEVO to [...]
Three new MROpen EVO in the USA
US Radiology Specialists Enhances Imaging Capabilities at its American [...]
DISCOVER MORE